AAAAAA

   
Results: 1-22 |
Results: 22
Variability of cytochrome P450 1A2 activity over time in young and elderlyhealthy volunteers
Authors: Simon, T Becquemont, L Hamon, B Nouyrigat, E Chodjania, Y Poirier, JM Funck-Brentano, C Jaillon, P
Citation: T. Simon et al., Variability of cytochrome P450 1A2 activity over time in young and elderlyhealthy volunteers, BR J CL PH, 52(5), 2001, pp. 601-604
Reduced costs with bisoprolol treatment for heart failure - An economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II)
Authors: Bacquet, P Levy, E McGuire, A McMurray, J Merot, JL Paschen, B Remme, WJ Szucs, TD Klein, W Brunhuber, W Hofmann, R Kuhn, P Nesser, HJ Slany, J Weihs, W Wiedermann, C Wimmer, H van Mieghem, W Boland, J Chaudron, JM Jordaens, L Melchior, JP Aschermann, M Bruthansl, J Hradec, M Kolbel, F Semrad, B Haghfelt, T Hansen, JF Goetzsche, CO Hildebrandt, P Kassis, E Rasmussen, V Rokkedal, J Thomassen, A Groundstroem, K Uusimaa, P Le Heuzey, JY Aumont, MC Aupetit, JF Baille, N Baudouy, P Belin, A Bonneau, A Bonneric, G Bousser, JP Citron, B Dary, P Decoulx, E De Groote, P Denolle, T Dievart, F Duriez, P Eicher, JC Enjuto, G Ferriere, M Fournier, E Garandeau, M Gauthier, J Genest, M Gerbe, A Godenir, JP Guillot, B Guillot, JP Guillot, P Heno, P d'Ivernois, C Jean, M Kacet, S Kalle, R Komajda, M Lacroix, A Lallemand, R Lardoux, H Marquet, M Martin, M Martin, O Mery, D Mossaz, R Mothes, P Olive, T Ostorero, M Paganelli, F Page, E Pauly-Laubry, C Puel, J Rousseau, JF Roux, JJ Schenowitz, A Sourdais, K Tremel, F Verdun, A Witchiz, S Wolf, JE Hombach, V Assmann, I Beyer, T Bischoff, KO Darius, H Ertl, G Fleck, E Forster, K Freytag, F Gleichmann, U Haasis, R Henssge, R Hey, D Hesse, P Hofs, T Keck, M Klein, H Kromer, ET Kruls-Munch, J Luderitz, B Maisch, B Mitrovic, V Neubauer, S Osterziel, KJ Simon, H Spitzer, SG Stohring, R Taubert, G Teichmann, W Theisen, K Wende, W Wieser, H Zotz, R Bridges, A Adgey, J Ambepitiya, G Boon, N Boyle, RM Cowley, AJ Cripps, T Davies, MK Dunn, F Findlay, J Forsey, P Fyfe, T Gould, B Greenwood, TW Hubner, P Khan, S Lewis, P Mackay, A Maltz, M McArthur, J McLeod, A McLeod, D Metcalfe, M Millar-Craig, M Mills, P Nelson, JK Nicholls, D Oakley, GD Patterson, DLH Pohl, JEF Ray, S Silke, B Wilkinson, PR Preda, I Csanady, M Cserhalmi, L Edes, I Gesztesi, T Karpati, P Simon, K Tarjan, J Fogari, R Tramarin, R Galie, N Giani, P Milanese, U Scalvini, S Scrutinio, D Sechi, LA Tettamanti, F De Vito, F Crean, P McCann, H Mulcahy, D Sugrue, D van Hoogenhuyze, DCA van der Burgh, PH Ciampricotti, R van Dantzig, JM DenHartog, FR Henneman, JA van Kesteren, HAM Kragten, JA Liem, KL Limburg, A van der Linde, MR Linssen, GCM Pasteuning, H Penn, HJAM Van Rossum, P Schaafsma, HJ Schelling, A Sloos, R Wesdorp, JCL Korewicki, J Achremczyk, P Czestockowska, E Dowgird, M Dyduszynski, A Gorski, J Ilmurzynska, K Janicki, K Kornacewicz-Jach, Z Kraska, T Krzeminska-Pakula, M Kuch, J Nartowicz, E Petelenz, T Piwowarska, W Rawczynska-Englert, I Ruzyllo, W Swiatecka, G Tendera, M Wierzchowiecki, M Wodniecki, J Wojciechowoski, D Wrabec, K Wysocki, H Gomes, RS Ceia, MF Lousada, N Campos, JMM Providencia, LA de Moura, ALZC Marejev, VJ Aronov, DM Arutjunov, GP Bart, BJ Basechikin, SS Belenkov, JN Beloussov, JB Bokeria, OA Charchogljan, RA Doschytsin, V Fedorova, TA Glezer, MG Gorbachenkov, A",Gorshkov,"Gospodarenko, AL Ivashkin, VT Ivleva, AJ Kyrichenko, AA Lavrov, AA Lazebnik, LB Marynov, A Mazaev, VP Polejev, NR",Shpektor,"Sidorenko, BA Sobolev, KE Starodoubtsev, AK Storozhakhov, GI Syrkin, AL Zodionchenko, VS Zvereva, TV Murin, J Kaliska, G Rybar, R Valle, V Artaza, M Conthe, P Cruz, JM Garcia-Moll, M Lopez-Sendon, JL Martinez, A Monzon, F Ribas, M Roig, E Roldan, I Hoglund, C Ekdahl, S Hjelmaeus, L Lindberg, K Lofdahl, P Ulvenstam, G Warselius, L Follath, F Anghern, W Dubach, P Erne, P Gallino, A Moccetti, T Jmouro, AV Dargie, HJ Erdmann, E Follath, F Hoglund, C Lechat, P Sendon, JLL Mareyev, V Remme, WJ Sadowski, Z Seabra-Gomes, RJ Zannad, F Wehrlen-Grandjean, M Funck-Brentano, C Hansen, S Hohnloser, S Vanoli, E Jaillon, P De Baker, G Dahlstrom, U Hill, C Leizorovicz, A Burgnard, F Rolland, C Wiemann, H Verkenne, P Arab, T Cussac, N Dussous, V Haise, S Funck-Brentano, C
Citation: P. Bacquet et al., Reduced costs with bisoprolol treatment for heart failure - An economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II), EUR HEART J, 22(12), 2001, pp. 1021-1031
Is diclofenac a valuable CYP2C9 probe in humans?
Authors: Morin, S Loriot, MA Poirier, JM Tenneze, L Beaune, PH Funck-Brentano, C Jaillon, P Becquemont, L
Citation: S. Morin et al., Is diclofenac a valuable CYP2C9 probe in humans?, EUR J CL PH, 56(11), 2001, pp. 793-797
Effect of grapefruit juice on digoxin pharmacokinetics in humans
Authors: Becquemont, L Verstuyft, C Kerb, R Brinkmann, U Lebot, M Jaillon, P Funck-Brentano, C
Citation: L. Becquemont et al., Effect of grapefruit juice on digoxin pharmacokinetics in humans, CLIN PHARM, 70(4), 2001, pp. 311-316
Comparison of sympathetic modulation induced by single oral doses of mibefradil, amlodipine, and nifedipine in healthy volunteers
Authors: Ragueneau, I Sao, AB Demolis, JL Darne, B Funck-Brentano, C Jaillon, P
Citation: I. Ragueneau et al., Comparison of sympathetic modulation induced by single oral doses of mibefradil, amlodipine, and nifedipine in healthy volunteers, CLIN PHARM, 69(3), 2001, pp. 122-129
Sex differences in the prognosis of congestive heart failure - Response
Authors: Simon, T Mary-Krause, M Funck-Brentano, C Jaillon, P
Citation: T. Simon et al., Sex differences in the prognosis of congestive heart failure - Response, CIRCULATION, 104(15), 2001, pp. E81-E81
Sex differences in the prognosis of congestive heart failure - Results from The Cardiac Insufficiency Bisoprolol Study (CIBIS II)
Authors: Simon, T Mary-Krause, M Funck-Brentano, C Jaillon, P
Citation: T. Simon et al., Sex differences in the prognosis of congestive heart failure - Results from The Cardiac Insufficiency Bisoprolol Study (CIBIS II), CIRCULATION, 103(3), 2001, pp. 375-380
Predictors of medical events and of their competitive interactions in the Cardiac Insufficiency Bisoprolol Study 2 (CIBIS-2)
Authors: Funck-Brentano, C Lancar, R Hansen, S Hohnloser, SH Vanoli, E
Citation: C. Funck-brentano et al., Predictors of medical events and of their competitive interactions in the Cardiac Insufficiency Bisoprolol Study 2 (CIBIS-2), AM HEART J, 142(6), 2001, pp. 989-997
Lymphocyte P-glycoprotein expression and activity before and after rifampicin in man
Authors: Becquemont, L Camus, M Eschwege, V Barbu, V Rey, E Funck-Brentano, C Jaillon, P
Citation: L. Becquemont et al., Lymphocyte P-glycoprotein expression and activity before and after rifampicin in man, FUN CL PHAR, 14(5), 2000, pp. 519-525
Steady-state versus non-steady-state QT-RR relationships in 24-hour Holterrecordings
Authors: Lande, G Funck-Brentano, C Ghadanfar, M Escande, D
Citation: G. Lande et al., Steady-state versus non-steady-state QT-RR relationships in 24-hour Holterrecordings, PACE, 23(3), 2000, pp. 293-302
Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects
Authors: Demolis, JL Kubitza, D Tenneze, L Funck-Brentano, C
Citation: Jl. Demolis et al., Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects, CLIN PHARM, 68(6), 2000, pp. 658-666
Combined glutathione-S-transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicity
Authors: Simon, T Becquemont, L Mary-Krause, M de Waziers, I Beaune, P Funck-Brentano, C Jaillon, P
Citation: T. Simon et al., Combined glutathione-S-transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicity, CLIN PHARM, 67(4), 2000, pp. 432-437
Predictors of medical events in patients enrolled in the Cardiac Insufficiency Bisoprolol Study (CIBIS): A study of the interactions between beta-blocker therapy and occurrence of critical events using analysis of competitive risks
Authors: Funck-Brentano, C Lancar, R Le Heuzey, JY Lardoux, H Soubrie, C Lechat, P
Citation: C. Funck-brentano et al., Predictors of medical events in patients enrolled in the Cardiac Insufficiency Bisoprolol Study (CIBIS): A study of the interactions between beta-blocker therapy and occurrence of critical events using analysis of competitive risks, AM HEART J, 139(2), 2000, pp. 262-271
Effects of cigarette smoking on short-term variability of blood pressure in smoking and non smoking healthy volunteers
Authors: Ragueneau, I Michaud, P Demolis, JL Moryusef, A Jaillon, P Funck-Brentano, C
Citation: I. Ragueneau et al., Effects of cigarette smoking on short-term variability of blood pressure in smoking and non smoking healthy volunteers, FUN CL PHAR, 13(4), 1999, pp. 501-507
Mibefradil, a potent CYP3A inhibitor, does not alter pravastatin pharmacokinetics
Authors: Becquemont, L Funck-Brentano, C Jaillon, P
Citation: L. Becquemont et al., Mibefradil, a potent CYP3A inhibitor, does not alter pravastatin pharmacokinetics, FUN CL PHAR, 13(2), 1999, pp. 232-236
Survival analysis example based on an event history model from a clinical trial in cardiology
Authors: Lancar, R Funck-Brentano, C
Citation: R. Lancar et C. Funck-brentano, Survival analysis example based on an event history model from a clinical trial in cardiology, REV EPIDEM, 47(6), 1999, pp. 613-618
Pharmacokinetic and pharmacodynamic drug interactions between digoxin and macrogol 4000, a laxative polymer, in healthy volunteers
Authors: Ragueneau, I Poirier, JM Radembino, N Sao, AB Funck-Brentano, C Jaillon, P
Citation: I. Ragueneau et al., Pharmacokinetic and pharmacodynamic drug interactions between digoxin and macrogol 4000, a laxative polymer, in healthy volunteers, BR J CL PH, 48(3), 1999, pp. 453-456
In vivo indices of enzyme activity: the effect of renal impairment on the assessment of CYP2D6 activity
Authors: Rostami-Hodjegan, A Funck-Brentano, C Kroemer, HK Tucker, GT
Citation: A. Rostami-hodjegan et al., In vivo indices of enzyme activity: the effect of renal impairment on the assessment of CYP2D6 activity, BR J CL PH, 47(5), 1999, pp. 577-578
A study of the relative bioavailability of cysteamine hydrochloride, cysteamine bitartrate and phosphocysteamine in healthy adult male volunteers
Authors: Tenneze, L Daurat, V Tibi, A Chaumet-Riffaud, P Funck-Brentano, C
Citation: L. Tenneze et al., A study of the relative bioavailability of cysteamine hydrochloride, cysteamine bitartrate and phosphocysteamine in healthy adult male volunteers, BR J CL PH, 47(1), 1999, pp. 49-52
Cytochrome P-450 3A4 and 2C8 are involved in zopiclone metabolism
Authors: Becquemont, L Mouajjah, S Escaffre, O Beaune, P Funck-Brentano, C Jaillon, P
Citation: L. Becquemont et al., Cytochrome P-450 3A4 and 2C8 are involved in zopiclone metabolism, DRUG META D, 27(9), 1999, pp. 1068-1073
How can our institutions optimize clinical research in France?
Authors: Funck-Brentano, C Brouard, R
Citation: C. Funck-brentano et R. Brouard, How can our institutions optimize clinical research in France?, THERAPIE, 54(4), 1999, pp. 479-484
Assessment of CYP2D6 and CY2C19 activity in vivo in humans: A cocktail study with dextromethorphan and chloroguanide alone and in combination
Authors: Tenneze, L Verstuyft, C Becquemont, L Poirier, JM Wilkinson, GR Funck-Brentano, C
Citation: L. Tenneze et al., Assessment of CYP2D6 and CY2C19 activity in vivo in humans: A cocktail study with dextromethorphan and chloroguanide alone and in combination, CLIN PHARM, 66(6), 1999, pp. 582-588
Risultati: 1-22 |